Significance of DNMT3b in Oral Cancer
Authors:
Open Access
- 1 January 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (3) , e89956
Abstract
The aim of this study was to explore specific molecular markers that could lead to new insights into the identification of innovative treatments. The role of DNMT3b and its predictive power in the prognosis of oral cancer were identified. Human oral cancer cell lines including SCC4 and SCC25 were selected for cellular experiments. Changes in tumor growth, aggressiveness and the responsible signaling pathway were investigated in vitro and in vivo. Furthermore, 125 oral cancer tissue specimens were analyzed using immunohistochemical staining on tissue microarray slides, and correlations calculated between the level of DNMT3b and the clinical outcome of patients. Our data revealed that inhibition of DNMT3b resulted in slower tumor growth, attenuated tumor invasion ability and epithelial mesenchymal transition, as determined by in vitro and in vivo experiments. Activated IL-6 signaling might be responsible to the induction of DNMT3b overexpression on oral cancer. Regarding clinical data, the incidence of DNMT3b immunoreactivity in oral cancer specimens was significantly higher than in non-malignant epithelium, and positively linked to expression of IL-6. Furthermore, expression of DNMT3b was significantly linked with the risk of lymph node involvement, disease recurrence and shorter survival in patients with pathological stage III-IV oral cancer. In conclusion, IL-6 –DNMT3b axis could be used to predict the prognosis of oral cancer in clinics, and targeting DNMT3b could represent a promising treatment strategy.Keywords
This publication has 33 references indexed in Scilit:
- IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagusMolecular Cancer, 2013
- Interleukin-6 as a therapy target in oral squamous carcinomaExpert Opinion on Therapeutic Targets, 2012
- Significance of the TGF-β1/IL-6 axis in oral cancerClinical Science, 2012
- Methylation in oral cancer and pre-cancerous lesions (Review)Oncology Reports, 2011
- Role of DNA methyltransferase 1 in pharyngeal cancer related to treatment resistanceHead & Neck, 2011
- Interleukin‐6 promotes tumorigenesis by altering DNA methylation in oral cancer cellsInternational Journal of Cancer, 2010
- Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology ConsortiumCancer Epidemiology, Biomarkers & Prevention, 2009
- High frequency of hypermethylation of p14, p15 and p16 in oral pre‐cancerous lesions associated with betel‐quid chewing in Sri LankaJournal of Oral Pathology & Medicine, 2008
- Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosaJournal of Cancer Research and Clinical Oncology, 2006
- The epigenetics of oral cancerInternational Journal of Oral and Maxillofacial Surgery, 2006